作为球形核酸构造物提供的DENV可以增强抗原呈现和免疫原性在体外和体内
Jing Zhao1, Jiuxiang He1, Xiaoyan Ding1
1College of Basic Medicine, Army Medical University, Chongqing, 400038, People's Republic of China.
International journal of nanomedicine
|September 25, 2024
概括
一种新型纳米疫苗,球形核酸-TBB (SNA-TBB),显示出对登革热病毒 (DENV) 的保护有希望. 这种登革热候选疫苗在临床前研究中有效诱导免疫反应,并防止感染.
科学领域:
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 登革热病毒 (DENV) 感染是一个全球性的健康问题,需要有效的疫苗.
- 类疫苗为广泛免疫提供了稳定性,安全性和灵活性.
- 球形核酸 (SNA) 通过模块化和免疫调节来增强类疫苗的疗效.
研究的目的:
- 开发和评估一种新型纳米疫苗,SNA-TBB,用于针对所有四种DENV血清型的广泛保护.
- 评估SNA-TBB的免疫性,疗效和安全性.
主要方法:
- 通过将SNA与DENV表位一起功能化SNA,合成了SNA-TBB.
- 物理化学性质的特征;在体外研究中评估了内细胞分裂,细胞毒性和树突细胞成熟.
- 在小鼠体内研究评估了抗体标位,对DENV的保护和器官安全.
主要成果:
- SNA-TBB表现出有利的物理化学特性和增强的细胞吸收.
- 试验室检测显示没有细胞毒性,促进树突细胞成熟,并提高了关键细胞因子水平.
- 活体免疫引发了高IgG抗体标位,并提供了对DENV感染的保护,没有观察到任何不良影响.
结论:
- SNA-TBB代表了DENV的一种有前途的纳米疫苗平台.
- 基于SNA的类疫苗是开发安全有效的抗病毒免疫疗法的可行策略.
更多相关视频
10:06Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization
Published on: September 2, 2022
1.8K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
Antigens Involved in Adaptive Immunity
470
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
470
Vaccinations
44.1K
Overview
44.1K
